The Development and Evaluation of a Co-designed, AI-based Information-providing Chatbot for Sarcoma Patients: A Pilot Randomised Controlled Trial
Sponsor: The Hong Kong Polytechnic University
Trial Details
| Condition | Sarcoma |
| Intervention | ASCC (sarcoma-specific AI chatbot); Routine Clinical Care |
| Phase | NA |
| Status | Not_yet_recruiting |
| Participants | 78 |
| Est. Completion | 31 July 2028 |
| Last Updated | 1 Apr 2026 |
Primary Outcome
Screening rate; Eligibility rate; Consent rate; Randomization rate; Attendance rate; Retention rate; Completion rate; Proportion of missing data; Adverse events
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * (1) diagnosed with soft tissue sarcoma; * (2) receiving active treatment at any stage; * (3) aged≥18 years; * (4) able to speak Cantonese, Mandarin and English; * (5) access to an electronic device enabling ASCC use Exclusion Criteria: * (1) patients with unstable physical or mental conditions; * (2) inability to communicate logically; * (3) using chatbots (e.g., ChatGPT, Deepseek) for sarcoma information in the last month; * (4) mental health disorders documented by the medical system
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service